METHOD FOR REDUCING INCIDENCE OF ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS IN AGE GROUP OF 3-6 YEARS Russian patent published in 2024 - IPC A61K35/747 A61K36/64 A61K9/14 A61K9/48 A61P31/12 A61P37/04 

FIELD: medicine; pediatrics.

SUBSTANCE: invention can be used to reduce the rate of acute respiratory viral infections (ARVI) in children of 3–6 years old with recurrent respiratory infections. Sequencing is used to determine the composition of the intestinal and oropharyngeal microbiome. In the presence of Firmicutes in oropharynx 25.87% or less, in intestine 24.88% or less; Actinobacteriota in oropharynx 1.07% or less, in intestine 3.65% or less; Proteobacteria in oropharynx 6.24% or more, in intestine 1.47% or more, children are treated with preparations for 3 months according to the following scheme: Saccharomyces boulardii CNCM I-745 lyophilisate 2 capsules 250 mg 2 times a day before meals; Lactobacillus reuteri DSM 17938 5 drops once a day before meals; Bac-Set Baby powder 1×10⁹ CFU, one sachet once a day in the morning with meals.

EFFECT: method provides reducing the number of ARVI episodes in children with recurrent respiratory infections, reducing the duration of the episode, reducing the risk of complications and the need for antibiotic therapy due to treatment with preparations for 3 months according to the original regimen.

1 cl, 3 tbl, 2 ex